2024 Biopharma Downfall: Major Layoffs and Facility Closures Shake the Industry
The biopharma industry, known for its innovative approaches to healthcare and drug development, has been shaken to its core in 2024 by a wave of significant layoffs and facility closures. Major players, including Bayer, Bristol Myers Squibb, and Johnson & Johnson, have initiated large-scale workforce reductions, reflecting a broader trend of companies reassessing their operational […]
Teva and Alvotech Unveil Revolutionary Biosimilar of Stelara with 85% Price Slash: A Game Changer for Immunosuppressive Treatments!
The biosimilar market has grown significantly in recent years, offering affordable alternatives to expensive biologic drugs. In a landmark announcement, Teva Pharmaceuticals, in collaboration with Alvotech, has introduced a biosimilar version of Stelara, Johnson & Johnson’s leading immunosuppressive treatment. This innovative product offers patients an unprecedented 85% price reduction, making it a truly game-changing option […]